Ionis Pharmaceuticals IONS Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's software and technology licenses, net?
- Ionis Pharmaceuticals (IONS) reported software and technology licenses, net of $135.56M in Q1 2026.
- How has Ionis Pharmaceuticals's software and technology licenses, net changed year-over-year?
- Ionis Pharmaceuticals's software and technology licenses, net increased by 2.8% year-over-year, from $131.82M to $135.56M.
- What is the long-term trend for Ionis Pharmaceuticals's software and technology licenses, net?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's software and technology licenses, net has grown at a 28.0% compound annual growth rate (CAGR), from $50.03M to $171.6M.